As novel technologies begin to make inroads into the biopharma industry, we have to consider what will come next and how beneficial it will be.

At the helm of SkinBioTherapeutics, Catherine O’Neill and her team are exploring the ways in which probiotic bacteria can be used topically.

As a leading partner and supplier to the industry, MilliporeSigma continues to strengthen and enhance its supply chain capabilities.

When it comes to formulation, many choices should be carefully considered – and regulators expect excipient selection to be justified.

Nominations are now open for The Medicine Maker 2020 Power List.

Meet the grand winner of The Medicine Maker 2018 Innovation Awards: Zydis Ultra!

Viral contamination can have devastating effects. But innovations upstream can help prevent that.

Helping to meet demands and reduce shortages... Is continuous manufacturing the way forward for pharma?

How can we reduce process risk and development times, streamline supply chains, lower costs and improve quality? Standardizing single-use.

Complex formulations bring complex technical challenges.